{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:32:27Z","timestamp":1792211547952,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T00:00:00Z","timestamp":1495152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1038\/eye.2017.78","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T13:03:16Z","timestamp":1495198996000},"page":"1417-1426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice"],"prefix":"10.1038","volume":"31","author":[{"given":"G","family":"Giannaccare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Bonifazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Arpinati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fresina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Bandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Cavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Versura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E C","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,19]]},"reference":[{"key":"BFeye201778_CR1","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1182\/blood-2011-03-344390","volume":"118","author":"S Arai","year":"2011","unstructured":"Arai S, Jagasia M, Storer B, Chai X, Pidala J, Cutler C et al. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. Blood 2011; 118: 4242\u20134249.","journal-title":"Blood"},{"key":"BFeye201778_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2008-10-182592","volume":"114","author":"J Pidala","year":"2009","unstructured":"Pidala J, Anasetti C, Jim H . Quality of life after allogenic hematopoietic cell transplantation. Blood 2009; 114: 7\u201319.","journal-title":"Blood"},{"key":"BFeye201778_CR3","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.1016\/S1542-0124(12)70203-3","volume":"3","author":"SK Kim","year":"2005","unstructured":"Kim SK . Ocular graft vs. host disease. Ocul Surf 2005; 3: S177\u2013S179.","journal-title":"Ocul Surf"},{"key":"BFeye201778_CR4","first-page":"351","volume":"8","author":"N Nassiri","year":"2013","unstructured":"Nassiri N, Eslani M, Panahi N, Mehravaran S, Ziaei A, Djalilian AR . Ocular graft versus host disease following allogeneic stem cell transplantation: a review of current knowledge and recommendations. J Ophthalmic Vis Res 2013; 8: 351\u2013358.","journal-title":"J Ophthalmic Vis Res"},{"key":"BFeye201778_CR5","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/bmt.2012.56","volume":"47","author":"R Jacobs","year":"2012","unstructured":"Jacobs R, Tran U, Chen H, Kassim A, Engelhardt BG, Greer JP et al. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant 2012; 47: 1470\u20131473.","journal-title":"Bone Marrow Transplant"},{"key":"BFeye201778_CR6","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.ophtha.2009.04.054","volume":"116","author":"KF Tabbara","year":"2009","unstructured":"Tabbara KF, Al-Ghamdi A, Al-Mohareb F, Ayas M, Chaudhri N, Al-Sharif F et al. Ocular findings after allogenic hematopoietic stem cell transplantation. Ophthalmology 2009; 116: 1624\u20131629.","journal-title":"Ophthalmology"},{"key":"BFeye201778_CR7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant 2005; 11: 945\u2013955.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFeye201778_CR8","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/ACI.0b013e328357b4b9","volume":"12","author":"M Hessen","year":"2012","unstructured":"Hessen M, Akpek EK . Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol 2012; 12: 540\u2013547.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"BFeye201778_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/01.icu.0000233952.09595.d8","volume":"17","author":"SK Kim","year":"2006","unstructured":"Kim SK . Update on ocular graft versus host disease. Curr Opin Ophthalmol 2006; 17: 344\u2013348.","journal-title":"Curr Opin Ophthalmol"},{"key":"BFeye201778_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant 2015; 21: 389\u2013401.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFeye201778_CR11","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1097\/ICO.0b013e3181ca321c","volume":"29","author":"AC Westeneng","year":"2010","unstructured":"Westeneng AC, Hettinga Y, Lokhorst H, Verdonck L, van Dorp S, Rothova A . Ocular graft-versus-host disease after allogenic stem cell transplantation. Cornea 2010; 29: 758\u2013763.","journal-title":"Cornea"},{"key":"BFeye201778_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/ICO.0000000000000340","volume":"34","author":"H Shikari","year":"2015","unstructured":"Shikari H, Amparo F, Saboo U, Dana R . Onset of ocular graft-versus-host disease symptoms after allogenic hematopoietic stem cell transplantation. Cornea 2015; 34: 243\u2013247.","journal-title":"Cornea"},{"key":"BFeye201778_CR13","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1097\/ICO.0b013e318276bc56","volume":"32","author":"Y Ivanir","year":"2013","unstructured":"Ivanir Y, Shimoni A, Ezra-Nimni O, Barequet IS . Prevalence of dry eye syndrome after allogenic hematopoietic stem cell transplantation. Cornea 2013; 32: e97\u2013e101.","journal-title":"Cornea"},{"key":"BFeye201778_CR14","doi-asserted-by":"publisher","first-page":"655","DOI":"10.5301\/ejo.5000451","volume":"24","author":"M Vanathi","year":"2014","unstructured":"Vanathi M, Kashyap S, Khan R, Seth T, Mishra P, Mahapatra M et al. Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients. Eur J Ophthalmol 2014; 24: 655\u2013666.","journal-title":"Eur J Ophthalmol"},{"key":"BFeye201778_CR15","first-page":"1105","volume":"17","author":"A Tichelli","year":"1996","unstructured":"Tichelli A, Duell T, Weiss M, Socie G, Ljungman P, Cohen A et al. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on late effects. Bone Marrow Transplant 1996; 17: 1105\u20131111.","journal-title":"Bone Marrow Transplant"},{"key":"BFeye201778_CR16","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1182\/blood.V98.6.1695","volume":"98","author":"D Przepiorka","year":"2001","unstructured":"Przepiorka D, Anderlini P, Saliba R, Cleary K, Mehra R, Khouri I et al. Chronic graft-versus-host disease after allogenic blood stem cell transplantation. Blood 2001; 98: 1695\u20131700.","journal-title":"Blood"},{"key":"BFeye201778_CR17","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1136\/bjo.83.10.1125","volume":"83","author":"Y Ogawa","year":"1999","unstructured":"Ogawa Y, Okamoto S, Wakui M, Watanabe R, Yamada M, Yoshino M et al. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol 1999; 83: 1125\u20131130.","journal-title":"Br J Ophthalmol"},{"key":"BFeye201778_CR18","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1038\/srep03419","volume":"3","author":"Y Ogawa","year":"2013","unstructured":"Ogawa Y, Kim SK, Dana R, Clayton J, Jain S, Rosenblatt MI et al. International Chronic Ocular Graft-vs-Host Disease (GVHD) Consensus Group: proposed criteria for chronic GVHD (Part I). Sci Rep 2013; 3: 3419.","journal-title":"Sci Rep"},{"key":"BFeye201778_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/ICO.0b013e318226bf97","volume":"31","author":"T Dietrich-Ntoukas","year":"2012","unstructured":"Dietrich-Ntoukas T, Cursiefen C, Westekemper H, Eberwein P, Reinhard T, Bertz H et al. Diagnosis and treatment of ocular chronic graft-versus-host disease: Report from the German\u2013Austrian\u2013Swiss Consensus Conference on Clinical Practice in Chronic GVHD. Cornea 2012; 31: 299\u2013310.","journal-title":"Cornea"},{"key":"BFeye201778_CR20","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/ICO.0000000000000747","volume":"35","author":"G Giannaccare","year":"2016","unstructured":"Giannaccare G, Bonifazi F, Sessa M, Fresina M, Arpinati M, Bandini G et al. Dry eye disease is already present in hematological patients before hematopoietic stem cell transplantation. Cornea 2016; 35: 638\u2013643.","journal-title":"Cornea"},{"key":"BFeye201778_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christanson MD, Jacobsen G, Hirsch JD, Reis BL . Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000; 118: 615\u2013621.","journal-title":"Arch Ophthalmol"},{"key":"BFeye201778_CR22","first-page":"221","volume":"21","author":"MA Lemp","year":"1995","unstructured":"Lemp MA . Report of the National Eye Institute\/Industry Workshop on clinical trials in dry eye. CLAO J 1995; 21: 221\u2013232.","journal-title":"CLAO J"},{"key":"BFeye201778_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1001\/archopht.1969.00990020012003","volume":"82","author":"OP Van Bijsterveld","year":"1969","unstructured":"Van Bijsterveld OP . Diagnostic tests in the sicca syndrome. Arch Ophthalmol 1969; 82: 10\u201314.","journal-title":"Arch Ophthalmol"},{"key":"BFeye201778_CR24","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/archopht.1989.01070020413046","volume":"107","author":"DA Jabs","year":"1989","unstructured":"Jabs DA, Wingard J, Green WR, Farmer ER, Vogelsang G, Saral R . The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 1989; 107: 1343\u20131348.","journal-title":"Arch Ophthalmol"},{"key":"BFeye201778_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1542-0124(12)70139-8","volume":"1","author":"GN Foulks","year":"2003","unstructured":"Foulks GN, Bron AJ . Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf 2003; 1: 107\u2013126.","journal-title":"Ocul Surf"},{"key":"BFeye201778_CR26","doi-asserted-by":"crossref","unstructured":"The epidemiology of dry eye disease: Report of the Epidemiology Subcommittee of the International Dry Eye WorkShop. (2007 Ocul Surf 2007; 5: 93\u2013107.","DOI":"10.1016\/S1542-0124(12)70082-4"},{"key":"BFeye201778_CR27","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1167\/iovs.10-5390","volume":"51","author":"BD Sullivan","year":"2010","unstructured":"Sullivan BD, Whitmer D, Nichols KK, Tomlinson A, Foulks GN, Geerling G et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci 2010; 51: 6125\u20136130.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye201778_CR28","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ajo.2004.04.052","volume":"138","author":"SC Pflugfelder","year":"2004","unstructured":"Pflugfelder SC, Maskin SL, Anderson B et al. A randomized, doublemasked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol 2004; 138: 444\u2013457.","journal-title":"Am J Ophthalmol"},{"key":"BFeye201778_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","volume":"13","author":"KH Wan","year":"2015","unstructured":"Wan KH, Chen LJ, Young AL . Efficacy and safety of topical 0.05% cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis. Ocul Surf 2015; 13: 213\u2013225.","journal-title":"Ocul Surf"},{"key":"BFeye201778_CR30","doi-asserted-by":"crossref","unstructured":"Management and therapy of dry eye disease: Report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5: 163\u2013178.","DOI":"10.1016\/S1542-0124(12)70085-X"},{"key":"BFeye201778_CR31","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/978-1-4615-0717-8_140","volume":"506","author":"DA Schaumberg","year":"2002","unstructured":"Schaumberg DA, Sullivan DA, Dana MR . Epidemiology of dry eye syndrome. Adv Exp Med Biol 2002; 506: 989\u2013998.","journal-title":"Adv Exp Med Biol"},{"key":"BFeye201778_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/sj.bmt.1705426","volume":"38","author":"SC Leite","year":"2006","unstructured":"Leite SC, de Castro RS, Alves M, Cunha DA, Correa ME, de Silveira LA et al. Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 38: 223\u2013227.","journal-title":"Bone Marrow Transplant"},{"key":"BFeye201778_CR33","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1136\/bjophthalmol-2014-306438","volume":"99","author":"JC Wang","year":"2015","unstructured":"Wang JC, Teichman JC, Mustafa M, O\u2019Donnell H, Broady R, Yeung SN . Risk factors for the development of ocular graft-versus-host disease (GVHD) dry eye syndrome in patients with chronic GVHD. Br J Ophthalmol 2015; 99: 1514\u20131518.","journal-title":"Br J Ophthalmol"},{"key":"BFeye201778_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/ICL.0000000000000064","volume":"41","author":"J Li","year":"2015","unstructured":"Li J, Zheng K, Deng Z, Zheng J, Ma H, Sun L et al. Prevalence and risk factors of dry eye disease among a hospital-based population in southeast China. Eye Contact Lens 2015; 41: 44\u201350.","journal-title":"Eye Contact Lens"},{"key":"BFeye201778_CR35","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/BF00404705","volume":"233","author":"T Hikichi","year":"1995","unstructured":"Hikichi T, Yoshida A, Fukui Y, Hamano T, Ri M, Araki K et al. Prevalence of dry eye in Japanese eye centers. Graefes Arch Clin Exp Ophthalmol 1995; 233: 555\u2013558.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFeye201778_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.clae.2013.09.009","volume":"37","author":"SN Onwubiko","year":"2014","unstructured":"Onwubiko SN, Eze BI, Udeh NN, Arinze OC, Onwasigwe EN, Umeh RE . Dry eye disease: prevalence, distribution and determinants in a hospital-based population. Cont Lens Anterior Eye 2014; 37: 157\u2013161.","journal-title":"Cont Lens Anterior Eye"},{"key":"BFeye201778_CR37","first-page":"789","volume":"110","author":"SK Basak","year":"2012","unstructured":"Basak SK, Pal PP, Basak S, Bandyopadhyay A, Choudhury S, Sar S . Prevalence of dry eye diseases in hospital-based population in West Bengal, Eastern India. J Indian Med Assoc 2012; 110: 789\u2013794.","journal-title":"J Indian Med Assoc"},{"key":"BFeye201778_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0301-4738.16170","volume":"53","author":"A Sahai","year":"2005","unstructured":"Sahai A, Malik P . Dry eye: prevalence and attributable risk factors in a hospital-based population. Indian J Ophthalmol 2005; 53: 87\u201391.","journal-title":"Indian J Ophthalmol"},{"key":"BFeye201778_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4103\/0974-620X.169910","volume":"8","author":"S Shah","year":"2015","unstructured":"Shah S, Jani H . Prevalence and associated factors of dry eye: our experience in patients above 40 years of age at a Tertiary Care Center. Oman J Ophthalmol 2015; 8: 151\u2013156.","journal-title":"Oman J Ophthalmol"},{"key":"BFeye201778_CR40","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/bmt.2009.312","volume":"45","author":"Y Wang","year":"2010","unstructured":"Wang Y, Ogawa Y, Dogru M, Tatematsu Y, Uchino M, Kamoi M et al. Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem celltransplantation in patients with or without chronic GVHD-related dry eye. Bone Marrow Transplant 2010; 45: 1077\u20131083.","journal-title":"Bone Marrow Transplant"},{"key":"BFeye201778_CR41","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/bmt.2015.72","volume":"50","author":"LA Engel","year":"2015","unstructured":"Engel LA, S Wittig S, Bock F, Sauerbier L, Scheid C, Holtick U et al. Meibography and meibomian gland measurements in ocular graft-versus-host disease. Bone Marrow Transplant 2015; 50: 961\u2013967.","journal-title":"Bone Marrow Transplant"},{"key":"BFeye201778_CR42","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1182\/blood-2014-01-514752","volume":"124","author":"G Soci\u00e9","year":"2014","unstructured":"Soci\u00e9 G, Ritz J . Current issues in chronic graft-versus-host disease. Blood 2014; 124: 374\u2013384.","journal-title":"Blood"},{"key":"BFeye201778_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJMoa1506002","volume":"374","author":"N Kroger","year":"2016","unstructured":"Kroger N, Solano C, Wolschke C, Bandini G, Patriarca F, Pini M et al. Antilymphocyte globuline for prevention of chronic graft-versus-host disease. N Engl J Med 2016; 374: 43\u201353.","journal-title":"N Engl J Med"},{"key":"BFeye201778_CR44","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/ICO.0000000000000436","volume":"34","author":"GE Boynton","year":"2015","unstructured":"Boynton GE, Raoof D, Niziol LM, Hussain M, Mian SI . Prospective randomized trial comparing efficacy of topical loteprednol etabonate 0.5% versus cyclosporine-A 0.05% for Treatment of dry eye syndrome following hematopoietic stem cell transplantation. Cornea 2015; 34: 725\u2013732.","journal-title":"Cornea"},{"key":"BFeye201778_CR45","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","volume":"21","author":"SJ Lee","year":"2015","unstructured":"Lee SJ, Wolff D, Kitko C, Koreth J, Inamoto Y, Jagasia M et al. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report. Biol Blood Marrow Transplant 2015; 21: 984\u2013999.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFeye201778_CR46","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ophtha.2011.08.040","volume":"119","author":"Y Inamoto","year":"2012","unstructured":"Inamoto Y, Chai X, Kurland BF, Cutler C, Flowers ME, Palmer JM et al. Validation of measurement scales in ocular graft-versus-host disease. Ophthalmology 2012; 119: 487\u2013493.","journal-title":"Ophthalmology"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye201778.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201778","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/eye.2017.78","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/eye201778.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:32:52Z","timestamp":1684431172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye201778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,19]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["BFeye201778"],"URL":"https:\/\/doi.org\/10.1038\/eye.2017.78","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,19]]},"assertion":[{"value":"21 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}